New drug discovery and molecules in clinical development against cancer stem cells.
Surface marker, transcription factors and signal transduction pathways in CSCs.
RNAi, miRNA, biologics, vaccines, etc. for targeting therapeutics against CSCs.
Plasticity model remains the most attractive hypothesis for designing targeted therapies.